These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37107120)

  • 21. Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine.
    Yan L; Xie S; Chen D; Pan Y; Tao Y; Qu W; Liu Z; Yuan Z; Huang L
    Sci Rep; 2017 Jun; 7(1):4064. PubMed ID: 28642571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics integration of danofloxacin against Eschrichia coli in piglet ileum ultrafiltration probe model.
    Yang Y; Cheng P; Xiao T; Ulziikhutag J; Yu H; Li J; Liu R; Muhammad I; Zhang X
    Sci Rep; 2021 Jan; 11(1):681. PubMed ID: 33436914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli.
    Wang J; Hao H; Huang L; Liu Z; Chen D; Yuan Z
    Front Microbiol; 2016; 7():36. PubMed ID: 26870006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies.
    San Martín B; Fresno M; Cornejo J; Godoy M; Ibarra R; Vidal R; Araneda M; Anadón A; Lapierre L
    PLoS One; 2019; 14(5):e0215174. PubMed ID: 31083666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1665-70. PubMed ID: 12019073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol Antimicrobial Susceptibility Testing in Cattle.
    Toutain PL; Sidhu PK; Lees P; Rassouli A; Pelligand L
    Front Microbiol; 2019; 10():1310. PubMed ID: 31244816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics of tylosin or florfenicol after a single intramuscular administration at two different doses of tylosin-florfenicol combination in pigs.
    Kim MH; Gebru E; Chang ZQ; Choi JY; Hwang MH; Kang EH; Lim JH; Yun HI; Park SC
    J Vet Med Sci; 2008 Jan; 70(1):99-102. PubMed ID: 18250580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
    Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
    Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against
    Lei Z; Liu Q; Xiong J; Yang B; Yang S; Zhu Q; Li K; Zhang S; Cao J; He Q
    Front Pharmacol; 2017; 8():542. PubMed ID: 28871226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of pharmacokinetic/pharmacodynamic (PK/PD) parameters of gatifloxacin on its bactericidal activity and resistance selectivity against clinical isolates of Streptococcus pneumoniae.
    Ebisu H; Kishii R; Takei M; Fukuda H
    J Infect Chemother; 2003 Sep; 9(3):210-4. PubMed ID: 14513387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
    Blondeau JM; Fitch SD
    PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
    Schnabel LV; Papich MG; Divers TJ; Altier C; Aprea MS; McCarrel TM; Fortier LA
    Equine Vet J; 2012 Jul; 44(4):453-8. PubMed ID: 21950341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.
    Zhang L; Li Y; Wang Y; Sajid A; Ahmed S; Li X
    J Vet Pharmacol Ther; 2018 Oct; 41(5):706-718. PubMed ID: 29696661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative plasma pharmacokinetics and tolerance of florfenicol following intramuscular and intravenous administration to camels, sheep and goats.
    Ali BH; Al-Qarawi AA; Hashaad M
    Vet Res Commun; 2003 Sep; 27(6):475-83. PubMed ID: 14582746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.
    Conte JE; Golden JA; Kipps J; Zurlinden E
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3508-15. PubMed ID: 15328118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against
    Zhou YF; Sun Z; Wang RL; Li JG; Niu CY; Li XA; Feng YY; Sun J; Liu YH; Liao XP
    Front Vet Sci; 2022; 9():811967. PubMed ID: 35187143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of florfenicol in serum and synovial fluid after regional intravenous perfusion in the distal portion of the hind limb of adult cows.
    Gilliam JN; Streeter RN; Papich MG; Washburn KE; Payton ME
    Am J Vet Res; 2008 Aug; 69(8):997-1004. PubMed ID: 18672962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.
    Sang K; Hao H; Huang L; Wang X; Yuan Z
    Front Vet Sci; 2015; 2():80. PubMed ID: 26779495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.